The estimated Net Worth of William C Olson is at least $282 ezer dollars as of 3 October 2011. William Olson owns over 2,605 units of Progenics Pharmaceuticals stock worth over $201,433 and over the last 19 years William sold PGNX stock worth over $80,542.
William has made over 35 trades of the Progenics Pharmaceuticals stock since 2005, according to the Form 4 filled with the SEC. Most recently William exercised 2,605 units of PGNX stock worth $12,035 on 3 October 2011.
The largest trade William's ever made was exercising 14,000 units of Progenics Pharmaceuticals stock on 4 May 2006 worth over $56,000. On average, William trades about 2,098 units every 56 days since 2005. As of 3 October 2011 William still owns at least 49,130 units of Progenics Pharmaceuticals stock.
You can see the complete history of William Olson stock trades at the bottom of the page.
Over the last 22 years, insiders at Progenics Pharmaceuticals have traded over $11,559,939 worth of Progenics Pharmaceuticals stock and bought 2,672,016 units worth $11,900,148 . The most active insiders traders include Healthcare Master Fund Ltd ..., Michael D Kishbauch és Bradley L Campbell. On average, Progenics Pharmaceuticals executives and independent directors trade stock every 16 days with the average trade being worth of $60,241. The most recent stock trade was executed by Capital, L.P.Altiva Managem... on 9 September 2019, trading 72,023 units of PGNX stock currently worth $359,395.
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.
Progenics Pharmaceuticals executives and other stock owners filed with the SEC include: